top of page
Search

SPARK vs. Clinical Genetic Testing for Autism: What's the Difference?

jrotenberg3
Sep 18
4 min read

A: We focus on people - individual kids and adults.

Research focusses on science and populations.

The goals and professional ethical frameworks are allied but different.


SPARK vs. Clinical Genetic Testing for Autism

Executive Summary

SPARK for Autism is a valuable, free research program that helps scientists understand the genetics of autism. Some participants receive a genetic result, but SPARK returns only selected pathogenic or likely pathogenic findings that meet its criteria and are confirmed by an independent clinical laboratory. [sparkforautism.org], [d2dxtcm9g2...dfront.net]

Clinical genetic testing serves a different purpose. It is selected for an individual patient based on the child’s medical history, developmental profile, examination, and diagnostic question.

The practical message for families: Participate in SPARK if eligible, but do not assume that participation replaces clinical genetic testing when an individualized genetic evaluation is medically indicated.

Quick Comparison

Feature

SPARK

Clinical genetic testing

Primary purpose

Autism research and genetic discovery

Individual diagnosis and medical care

Cost

Free to eligible participants

Insurance coverage and costs vary

Testing approach

Research analysis under SPARK protocols

Testing selected for the individual patient

Findings reported

Selected pathogenic or likely pathogenic findings meeting SPARK criteria

Findings included under the clinical laboratory’s test and reporting policy

Uncertain variants

SPARK states that uncertain variants are not returned

Clinical testing may produce uncertain results

Additional testing

Does not represent a complete clinical genetics evaluation

Other tests may be selected according to the child’s presentation

Best role

Research participation with possible personal benefit

Individualized diagnostic evaluation

What Is SPARK?

Visit the official SPARK website to learn about this long-term autism research program. Participation is free, and autistic individuals living in the United States and eligible family members may participate. [sparkforautism.org]

SPARK returns selected variants that an independent clinical laboratory classifies as pathogenic or likely pathogenic. It does not return variants classified as uncertain. The program updates its gene list as scientific knowledge changes. Read how SPARK determines which results to return. [sparkforautism.org]

SPARK also evaluates qualifying copy-number variants involving larger DNA regions associated with neurodevelopmental conditions. Review SPARK’s current gene list and copy-number criteria. [sparkforautism.org]

How Often Does SPARK Identify a Finding?

A 2024 study evaluated 21,532 autistic SPARK participants and 17,785 parents using microarray genotyping and exome sequencing. Researchers identified returnable pathogenic or likely pathogenic variants in 1,861 autistic participants, or 8.6% of those analyzed. Read the study on PubMed. [pubmed.ncb...lm.nih.gov]

This figure describes the published study population. It does not guarantee that an individual participant will receive a result.

How Is Clinical Genetic Testing Different?

Clinical genetic testing starts with an individual question:

Does this child have a genetic diagnosis relevant to medical care, prognosis, monitoring, or family counseling?

The clinician selects testing based on the child’s presentation and previous results. Depending on the clinical question, testing may include:

  • Chromosomal microarray

  • Fragile X testing

  • A targeted gene panel

  • Whole-exome sequencing

  • Whole-genome sequencing

  • Parental or other family testing

Not every child requires every test. No single test detects every type of genetic change.

The principal advantage of clinical testing is not simply that it may report more variants. It is that testing is selected and interpreted for the individual patient.

The Most Important Difference: What Gets Reported

SPARK uses a focused return-of-results system. It returns selected pathogenic or likely pathogenic findings satisfying its evidence criteria, and it does not return variants of uncertain significance. [sparkforautism.org]

A clinical laboratory reports findings according to the specific test and its reporting policy. Clinical testing may produce a definitive result, an uncertain result, or no explanatory finding.

Therefore:

  • SPARK asks: What can researchers learn about autism genetics, and does a participant have a finding that meets SPARK’s return criteria?

  • Clinical testing asks: Does this individual child have a genetic finding relevant to diagnosis or medical care?

Can Families Do Both?

Yes. The two approaches can serve complementary purposes.

SPARK gives families an opportunity to support autism research and potentially receive a qualifying genetic finding. Clinical testing provides an individualized evaluation when medically indicated.

A family that has not received a SPARK result should not conclude that autism has no genetic contribution. It means that SPARK has not returned a finding meeting its criteria to that participant.

Bottom Line

I encourage eligible families to consider participating in SPARK. It is an important autism research initiative and may provide valuable information.

However, SPARK is not the same as clinical genetic testing and should not automatically be considered a replacement for an individualized clinical genetics evaluation.

For many families, the answer is not SPARK or clinical testing. It is SPARK and clinical testing, when clinical testing is medically indicated.

References


Keywords: autism genetic testing, SPARK autism study, clinical genetic testing, autism genetics, whole exome sequencing, whole genome sequencing, pediatric neurology, autism diagnosis, genetic testing for autism, developmental delay genetic testing.

 
 
 

Comments

bottom of page